𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Resistance to pretransplant imatinib therapy may adversely affect the outcome of allogeneic stem cell transplantation in CML

✍ Scribed by Weisser, M; Schmid, C; Schoch, C; Hiddemann, W; Kolb, H J

Book ID
110014804
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
73 KB
Volume
36
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The extent of minimal residual disease r
The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
✍ Seok Lee; Yoo-Jin Kim; Nak-Gyun Chung; Jihyang Lim; Dong-Gun Lee; Hee-Je Kim; Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

## Abstract ## BACKGROUND: Previously, the authors demonstrated the positive impact of imatinib on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph‐positive ALL). Here, the authors analyzed for risk factors that af